1177-8881

Drug Design Development and Therapy

Dove Medical Press

View prefix report (10.2147)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 5704 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact5704 DOIs
2

Deposit reference lists for 2852 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact2852 DOIs
3

Attach ORCID iDs across 2795 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact2795 DOIs

DOIs for this ISSN

Showing the top 5 of 5703 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Metal complexes in cancer therapy – an update from… (10.2147/dddt.s119488)
Abstract References ORCID
220.98 883
2 Preparation, characterization, and potential application of… (10.2147/dddt.s99651)
Abstract References ORCID
208.20 596
3 8-Hydroxyquinolines: a review of their metal chelating prope… (10.2147/dddt.s49763)
Abstract References ORCID
195.24 400
4 Molecular mechanisms of cisplatin resistance in cervical can… (10.2147/dddt.s106412)
Abstract References ORCID
190.15 342
5 Drugs in development for toxoplasmosis: advances, challenges… (10.2147/dddt.s60973)
Abstract References ORCID
186.22 303
6 Update on developments with SGLT2 inhibitors in the manageme… (10.2147/dddt.s50773)
Abstract References ORCID
183.42 278
7 Metformin: a review of its potential indications (10.2147/dddt.s141675)
Abstract References ORCID
182.71 272
8 Proteinopathy, oxidative stress and mitochondrial dysfunctio… (10.2147/dddt.s130514)
Abstract References ORCID
181.99 266
9 Animal models of ischemic stroke and their application in cl… (10.2147/dddt.s56071)
Abstract References ORCID
179.19 244
10 Animal models and therapeutic molecular targets of cancer: u… (10.2147/dddt.s49584)
Abstract References ORCID
176.99 228
11 Albumin-bound paclitaxel in solid tumors: clinical developme… (10.2147/dddt.s88023)
Abstract References ORCID
176.70 226
12 Receptor tyrosine kinase (c-Kit) inhibitors: a potential the… (10.2147/dddt.s89114)
Abstract References ORCID
174.78 213
13 Current and emerging drugs for the treatment of inflammatory… (10.2147/dddt.s11290)
Abstract References ORCID
174.48 211
14 Baicalein induces apoptosis and autophagy of breast cancer c… (10.2147/dddt.s181939)
Abstract References ORCID
173.85 207
15 ACAM2000™: The new smallpox vaccine for United Sta… (10.2147/dddt.s3687)
Abstract References ORCID
173.54 205
16 <p>Ketamine and depression: a narrative review</p&g… (10.2147/dddt.s221437)
Abstract References ORCID
170.91 189
17 Studies of selective TNF inhibitors in the treatment of brai… (10.2147/dddt.s67655)
Abstract References ORCID
169.86 183
18 Microbubble-mediated ultrasound therapy: a review of its pot… (10.2147/dddt.s31564)
Abstract References ORCID
169.68 182
19 Phase III study of pasireotide long-acting release in patien… (10.2147/dddt.s84177)
Abstract References ORCID
169.51 181
20 2-Amino-1,3,4-thiadiazole as a potential scaffold for promis… (10.2147/dddt.s155958)
Abstract References ORCID
169.15 179
21 Ferulic acid attenuates liver fibrosis and hepatic stellate… (10.2147/dddt.s186726)
Abstract References ORCID
167.85 172
22 <p>Emodin alleviates myocardial ischemia/reperfusion i… (10.2147/dddt.s195412)
Abstract References ORCID
167.85 172
23 Effect of vitamin C on inflammation and metabolic markers in… (10.2147/dddt.s83144)
Abstract References ORCID
167.28 169
24 Clinical development of galunisertib (LY2157299 monohydrate)… (10.2147/dddt.s86621)
Abstract References ORCID
166.11 163
25 Primary prevention of coronary heart disease: integration of… (10.2147/dddt.s14934)
Abstract References ORCID
165.51 160
26 Emerging options for the management of scorpion stings (10.2147/dddt.s24754)
Abstract References ORCID
165.51 160
27 Apatinib for molecular targeted therapy in tumor (10.2147/dddt.s97235)
Abstract References ORCID
165.51 160
28 The spice for joint inflammation: anti-inflammatory role of… (10.2147/dddt.s117432)
Abstract References ORCID
164.48 155
29 <p>Protective Effects of Chlorogenic Acid on Cerebral… (10.2147/dddt.s228751)
Abstract References ORCID
164.27 154
30 Gut microbiota–derived short-chain fatty acids and… (10.2147/dddt.s150825)
Abstract References ORCID
163.64 151
31 Efficacy of nystatin for the treatment of oral candidiasis:… (10.2147/dddt.s100795)
Abstract References ORCID
163.42 150
32 Intracellular trafficking of new anticancer therapeutics: an… (10.2147/dddt.s135571)
Abstract References ORCID
163.42 150
33 Upregulation of PD-L1 and APE1 is associated with tumorigene… (10.2147/dddt.s75152)
Abstract References ORCID
162.99 148
34 Efficacy and safety of iron-chelation therapy with deferoxam… (10.2147/dddt.s79458)
Abstract References ORCID
161.88 143
35 Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER… (10.2147/dddt.s137783)
Abstract References ORCID
161.42 141
36 Crizotinib: a novel and first-in-class multitargeted tyrosin… (10.2147/dddt.s19045)
Abstract References ORCID
161.42 141
37 Pancreatic cancer: optimizing treatment options, new, and em… (10.2147/dddt.s60328)
Abstract References ORCID
160.96 139
38 Curcumin alleviates rheumatoid arthritis-induced inflammatio… (10.2147/dddt.s175763)
Abstract References ORCID
159.78 134
39 Vitamin D deficiency and the risk of tuberculosis: a meta-an… (10.2147/dddt.s79870)
Abstract References ORCID
159.78 134
40 Altered γ-aminobutyric acid neurotransmission in m… (10.2147/dddt.s62912)
Abstract References ORCID
159.53 133
41 Synergistic effects of antimicrobial peptide DP7 combined wi… (10.2147/dddt.s107195)
Abstract References ORCID
159.04 131
42 Drug delivery strategies to enhance the permeabilit… (10.2147/dddt.s79592)
Abstract References ORCID
158.80 130
43 Impact of streptozotocin on altering normal glucose homeosta… (10.2147/dddt.s79885)
Abstract References ORCID
158.29 128
44 Oral and transdermal drug delivery systems: role of lipid-ba… (10.2147/dddt.s103505)
Abstract References ORCID
157.79 126
45 Abiraterone acetate: oral androgen biosynthesis inhibitor fo… (10.2147/dddt.s15850)
Abstract References ORCID
157.53 125
46 Intranasal agomelatine solid lipid nanoparticles to enhance… (10.2147/dddt.s102500)
Abstract References ORCID
156.21 120
47 Reference ranges for antiepileptic drugs revisited: a practi… (10.2147/dddt.s154388)
Abstract References ORCID
156.21 120
48 Gallic acid attenuates dextran sulfate sodium-induced experi… (10.2147/dddt.s86345)
Abstract References ORCID
156.21 120
49 Rituximab for the treatment of rheumatoid arthritis: an upda… (10.2147/dddt.s41645)
Abstract References ORCID
155.94 119
50 Liraglutide and obesity: a review of the data so far (10.2147/dddt.s58459)
Abstract References ORCID
155.94 119